IPO - IPO roundup: NVL TEM and more
2024-06-10 09:31:57 ET
The IPO market last week saw a mix of activity. While industrial giant Novelis ( NVL ) surprisingly postponed its $878M IPO, marking the biggest delay since Clarios in mid-2021, heavyweights like hospital billing platform Waystar ( NASDAQ: WAY ) raised $968M by pricing its offering at the midpoint of the expected range. However, its stock price dipped 4% on its debut day. The upcoming week promises further action, with precision medicine company Tempus AI ( TEM ) set to raise $400M and Australian firm Telix Pharmaceuticals ( TLX ) planning to raise $200M. The Renaissance IPO ETF ( NYSEARCA: IPO ) has gained 4.6% YTD, trailing the 12.1% return of the S&P 500....
IPO roundup: NVL, TEM, and more